A recent report published by the American Academy of Neurology highlights a concerning trend in newborn health care. More parents in the United States and other countries are declining a routine vitamin K injection for their babies, despite strong medical evidence that the shot prevents life-threatening bleeding in newborns.
This growing refusal has sparked alarm among pediatricians and neurologists, especially as new data suggests that babies who do not receive the injection are dramatically more likely to suffer brain bleeds, long-term neurological damage, or even death. Here is what the research shows, why vitamin K is so important at birth, and what experts want parents to understand.
Vitamin K is an essential nutrient that helps blood clot properly. Without enough vitamin K, the body cannot effectively stop bleeding. While older children and adults get vitamin K from food and gut bacteria, newborn babies are born with very low levels of this critical vitamin.
Because of this natural deficiency, doctors recommend that all newborns receive a single vitamin K injection shortly after birth. This injection is not a vaccine. It is a vitamin supplement designed to prevent a condition known as vitamin K deficiency bleeding, also called VKDB.
VKDB can occur within days or even weeks after birth. In some cases, it leads to internal bleeding, including bleeding inside the brain. These brain hemorrhages can result in permanent neurological damage or death.
According to findings scheduled for presentation at the upcoming annual meeting of the American Academy of Neurology in April 2026, refusal rates for the vitamin K shot appear to be increasing in certain regions.
Researchers analyzed data from 25 previous studies examining vitamin K refusal and the incidence of vitamin K deficiency bleeding. In Minnesota, refusal rates rose from 0.9 percent in 2015 to 1.6 percent in 2019. In California, Connecticut, and Iowa, rates ranged from 0.2 percent to 1.3 percent.
Although these percentages may seem small, even a slight increase can have serious consequences. Hospital staff surveys suggest that more than half of health care workers have experienced growing resistance or pushback from parents regarding the vitamin K injection.
International data show similar patterns. Refusal rates ranged from 1 percent to 3 percent in Canada, New Zealand, and Scotland.
The most alarming finding from the review is the dramatic increase in risk for babies who do not receive the shot.
Researchers reported that newborns who skip the vitamin K injection are 81 times more likely to develop dangerous bleeding. Among infants diagnosed with vitamin K deficiency bleeding:
These numbers underscore how severe the consequences can be. Brain bleeding in newborns may not always be immediately obvious. Symptoms can include excessive bruising, bleeding from the nose or umbilical stump, seizures, lethargy, or vomiting. By the time symptoms appear, significant damage may already have occurred.
Researchers found that vitamin K refusal often reflects broader skepticism toward medical interventions.
In the United States, parents who declined the vitamin K shot were 90 times more likely to also refuse the hepatitis B vaccine and antibiotic eye ointment designed to prevent infections that can cause blindness. In Canada, parents who refused the injection were 15 times more likely to avoid routine childhood vaccinations by 15 months. In New Zealand, the likelihood was 14 times higher.
Common concerns among parents include:
However, medical experts emphasize that the injection has been used safely for decades and has a strong record of effectiveness.
According to pediatric health experts, the vitamin K injection given at birth is both safe and effective. It contains a small dose of vitamin K1, which the body uses to activate proteins necessary for blood clotting.
Adverse reactions are extremely rare. The injection may cause brief discomfort at the injection site, similar to any routine shot. Serious side effects are uncommon.
Extensive research over many years has not demonstrated a credible link between the vitamin K shot and chronic diseases. Medical organizations continue to recommend universal administration for newborns.
Dr. Kate Semidey, assistant professor of pediatrics at Florida International University in Miami and lead researcher on the review, emphasized the importance of education during pregnancy.
She and her colleagues suggest that prenatal counseling can help address misconceptions before delivery. When parents receive accurate, evidence-based information in advance, they may feel more confident about consenting to the injection.
Health care professionals are encouraged to discuss:
Clear communication may help reduce refusal rates and protect more infants from preventable harm.
One of the key reasons the vitamin K injection is administered immediately after birth is that early protection is critical. Some forms of vitamin K deficiency bleeding occur within the first week of life. Others, known as late VKDB, can happen between two weeks and six months of age, particularly in exclusively breastfed infants who did not receive the shot.
Oral vitamin K regimens have been studied in some countries. However, they typically require multiple doses and strict adherence. The single injection given at birth provides reliable and long-lasting protection without the need for follow-up dosing.
While refusal rates remain under 1 percent in most U.S. hospitals, even small increases can reverse decades of progress in preventing vitamin K deficiency bleeding.
Historically, before routine vitamin K administration became standard practice in the 1960s, VKDB was far more common. The introduction of universal newborn supplementation significantly reduced cases of severe bleeding and related brain injury.
Experts worry that misinformation shared through social media platforms may contribute to rising hesitation. Public health campaigns may need to adapt to address these concerns directly and transparently.
For parents weighing their options, it is important to rely on credible medical sources and consult directly with pediatricians or obstetric providers. Decisions about newborn care can feel overwhelming, especially with conflicting information available online.
Key facts to keep in mind:
The overwhelming consensus in the medical community is that the benefits of the vitamin K shot far outweigh the minimal risks.
The findings presented at the American Academy of Neurology annual meeting are considered preliminary until published in a peer-reviewed journal. However, the data align with existing knowledge about vitamin K deficiency bleeding and its preventable nature.
As awareness grows about increasing refusal rates, health professionals may intensify efforts to provide clear, compassionate education. The goal is not to pressure parents, but to ensure that decisions are based on accurate scientific evidence rather than misinformation.
Protecting newborns during their first hours of life can have lifelong implications. The vitamin K shot remains one of the simplest and most effective interventions in modern neonatal care.
American Academy of Neurology, news release, February 26, 2026.
This article is for informational and educational purposes only. It does not provide medical advice, diagnosis, or treatment. Statistical data discussed reflects general trends and may not apply to individual cases. Health decisions should always be made in consultation with a qualified health care professional who can provide personalized guidance based on individual circumstances.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.